Lasers, lights, and compounds for melasma in aesthetics
| Autor: | Mitalee P Christman, Kanika Kamal, Kerry Heitmiller |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
medicine.medical_specialty
Modalities Esthetics Melasma business.industry Lasers Usually asymptomatic Dermatology medicine.disease Melanosis Oral agents Treatment Outcome Quality of life (healthcare) Tranexamic Acid Treatment compliance Psychosocial stress Quality of Life medicine Humans business Tranexamic acid medicine.drug |
| Zdroj: | Clinics in Dermatology. 40:249-255 |
| ISSN: | 0738-081X |
| Popis: | Melasma is a chronic and relapsing skin condition. Although melasma is usually asymptomatic, it can be associated with immense psychosocial stress and greatly impact a patient's quality of life. Over the years, many different treatments have been used, ranging from daily photoprotection, topical lightening creams, and oral agents to laser and light-based therapies; however, efficacy is often limited with such treatments, and there is currently no effective modality to prevent recurrence. While treatment strategies had originally centered on the use of hydroquinone, newer modalities now include oral tranexamic acid and lasers. We examined previous and ongoing debates related to melasma treatments and have reviewed the current efficacy and safety of available treatments. Critical components essential to the successful management of melasma are the setting of patient expectations and assurance of treatment compliance. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect